Advance Cell Technology to Present at 2013 Aegis Capital Healthcare Conference
September 25 2013 - 8:30AM
Business Wire
CFO Ted Myles to also Present at StemCells
& Regenerative Medicine Congress
Advanced Cell Technology, Inc. (âACTâ;OTCQB:ACTC), a leader
in the field of regenerative medicine, today announced that
Chairman and CEO Gary Rabin will present a corporate overview at
the 2013 Aegis Capital Healthcare Conference. The presentation will
take place on Thursday, September 26 at 11 am PT at The Encore at
Wynn Las Vegas in Las Vegas, NV. A question and answer session will
follow Mr. Rabinâs formal remarks.
Advanced Cell Technology CFO and Executive Vice President of
Corporate Development, Ted Myles, will present at the StemCells
& Regenerative Medicine Congress. The presentation will take
place on Monday, September 30th at 11:40 am ET at the Hyatt Regency
in Cambridge, MA.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company
applying cellular technology in the field of regenerative medicine.
For more information, visit http://www.advancedcell.com or connect
with the Company on Facebook, Twitter, LinkedIn, Google+, and
YouTube.
Forward-Looking Statements
Statements in this news release regarding future financial and
operating results, the relevance and applicability of clinical
trials in animals to studying the effect of products in humans,
future growth in animal and human research and development
programs, potential new applications of and expanded indications
covering our technology, the effects of donorless sources of stem
cells on potency and the risk of communicable diseases in the
manufacturing context, the existence and size of potential or
existing market opportunities for the company, the effect of the
companyâs products on the medical needs and quality of life of
pets, and any other statements about the future expectations,
beliefs, goals, plans, or prospects expressed by management
constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Any statements
that are not statements of historical fact (including statements
containing the words âwill,â âbelieves,â âplans,â
âanticipates,â âexpects,â âestimates,â and similar
expressions) should also be considered to be forward-looking
statements. There are a number of important factors that could
cause actual results or events to differ materially from those
indicated by such forward-looking statements, including: limited
operating history, need for and limited sources of future capital,
failures or delays in obtaining regulatory approval of products,
risks inherent in the development and commercialization of
potential products, reliance on new and unproven technology in the
development of products, protection of our intellectual property,
and economic conditions generally. Additional information on
potential factors that could affect our results and other risks and
uncertainties are detailed from time to time in the companyâs
periodic reports, including the Quarterly Report on Form 10-Q for
the three months ended June 30, 2013. Forward-looking statements
are based on the beliefs, opinions, and expectations of the
companyâs management at the time they are made, and the company
does not assume any obligation to update its forward-looking
statements if those beliefs, opinions, expectations, or other
circumstances should change. Forward-looking statements are based
on the beliefs, opinions, and expectations of the companyâs
management at the time they are made, and the company does not
assume any obligation to update its forward-looking statements if
those beliefs, opinions, expectations, or other circumstances
should change. There can be no assurance that the Companyâs
clinical trials will be successful.
Investors:CEOcast, Inc.Bob Woods, 212-732-4300orPress:Russo
PartnersDavid Schull, 212-845-4271